Therapeutic Dose of Amitriptyline for Older Patients with Burning Mouth Syndrome
Takayuki Suga,1 Miho Takenoshita,1 Takeshi Watanabe,1 Trang TH Tu,1 Lou Mikuzuki,1 Chaoli Hong,1 Kazuhito Miura,2 Tatsuya Yoshikawa,1 Takahiko Nagamine,3 Akira Toyofuku1 1Department of Psychosomatic Dentistry, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo...
Guardado en:
Autores principales: | Suga T, Takenoshita M, Watanabe T, Tu TTH, Mikuzuki L, Hong C, Miura K, Yoshikawa T, Nagamine T, Toyofuku A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aede72ddda0f4b9fb106bc5f474e836e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Low-dose aripiprazole for refractory burning mouth syndrome
por: Umezaki Y, et al.
Publicado: (2016) -
Burning Mouth Syndrome: An Enigma
por: Mubeen,K, et al.
Publicado: (2011) -
THERAPEUTIC EFFECT OF AMITRIPTYLINE IN MANAGEMENT OF CHRONIC LOW BACK PAIN
por: A Ahmadi Ahangar,, et al.
Publicado: (2008) -
Evaluation of a Protocol For Topical Application of Capsaicine Gel 0.025 % in the Management of Burning Mouth Syndrome Correlating its Impact on Quality of Life
por: Ricken,Carla Militão, et al.
Publicado: (2021) -
Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
por: Reem Hanna, et al.
Publicado: (2021)